Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 3.37 ▼ -0.04 (-1.17%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pluristem Therapeutics Inc | PSTI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.08 | -2.29% | 3.41 | 3.51 | 3.38 | 3.51 | 3.49 | 19:59:39 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.00 | 14.89 | 11.89 | 79.85% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 166 | 23,340 | $ 3.44 | $ 80,330 | 64,800 | 3.11 - 11.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:48:18 | formt | 150 | $ 3.37 | USD |
Pluristem Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 53.58M | 15.71M | $ -26.13M | -28.97 | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 307.14k | 10.80% |
Pluristem Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSTI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.78 | 3.83 | 3.38 | 3.59 | 46,739 | -0.37 | -9.79% |
| 1 Month | 3.28 | 4.67 | 3.11 | 3.56 | 56,595 | 0.13 | 3.96% |
| 3 Months | 4.26 | 4.67 | 3.11 | 3.54 | 50,524 | -0.85 | -19.95% |
| 6 Months | 5.70 | 6.998 | 3.11 | 4.94 | 164,628 | -2.29 | -40.18% |
| 1 Year | 8.451 | 11.90 | 3.11 | 6.71 | 309,475 | -5.04 | -59.65% |
| 3 Years | 15.30 | 21.20 | 3.11 | 11.69 | 344,206 | -11.89 | -77.71% |
| 5 Years | 25.936 | 37.80 | 3.11 | 13.87 | 288,494 | -22.53 | -86.85% |
Pluristem Therapeutics Description
| Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Pluristem operates through the single business segment being Development of placenta-based cell therapy product. |
